Prologis to Announce Second Quarter 2025 Results July 16th
SAN FRANCISCO, June 16, 2025 /PRNewswire/ —Â Prologis, Inc. (NYSE: PLD) will host a webcast and conference call with senior management to discuss its second... Read more.
Adetayo Olantinwo Named Glenmeadow Vice President for Human Resources
LONGMEADOW, Mass., June 16, 2025 /PRNewswire/ — Glenmeadow, Inc., the exemplary provider of senior retirement lifestyle options, has selected Adetayo Olatinwo... Read more.
Dozens of Leading National Organizations Advocate for Millions of Workers Facing Life-Threatening Impacts of Extreme Heat
Heat Justice Now Coalition and Organizing Resilience are kicking off ‘Heat Week’ to support OSHA’s proposed heat stress rule and bring attention... Read more.
TAL Education Group Files Its Annual Report on Form 20-F
BEIJING, June 16, 2025 /PRNewswire/ — TAL Education Group (“TAL” or the “Company”) (NYSE: TAL), a smart learning solutions provider... Read more.
Inkbit Introduces: Cyclic Olefin Thermosets
A Class of Low-Loss Materials Designed for Radio Frequency and mmWave Applications MEDFORD, Mass., June 16, 2025 /PRNewswire/ — Inkbit, a MIT spinout pioneering... Read more.
Waystar Appoints Aashima Gupta and Michael Roman to Board of Directors
New directors bring deep expertise in AI innovation, healthcare, and enterprise growth LEHI, Utah and LOUISVILLE, Ky., June 16, 2025 /PRNewswire/ — Waystar... Read more.
Blue Acquisition Corp. Completes $201,250,000 Initial Public Offering
NEWPORT BEACH, Calif., June 16, 2025 /PRNewswire/ — Blue Acquisition Corp. (the “Company”) (Nasdaq: BACCU) announced today the closing of its initial... Read more.
Digital Turbine Reports Fiscal 2025 Fourth Quarter and Fiscal Year 2025 Financial Results
Fourth Quarter Revenue Totaled $119.2 Million, Representing Year-over-Year Growth of 6% Fourth Quarter GAAP Net Loss of $18.8 Million and GAAP EPS of ($0.18);... Read more.
Enliven Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
BOULDER, Colo., June 16, 2025 /PRNewswire/ — Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company... Read more.
Spyre Therapeutics to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trials for its SPY002 Program, its Novel Half-Life Extended Anti-TL1A Antibodies on June 17, 2025
WALTHAM, Mass., June 16, 2025 /PRNewswire/ — Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody... Read more.